NCT04720001View on ClinicalTrials.gov

Florbetaben PET Imaging in PPA

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

August 23, 2018

Primary Completion Date

January 21, 2021

Study Completion Date

February 26, 2021

Conditions
Primary Progressive AphasiaAlzheimer Disease
Interventions
DRUG

Florbetaben F18

A single injection of 8.1mCi of florbetaben F18 will be administered by intravenous bolus injection

DEVICE

PET

PET Scan for brain imaging

Trial Locations (1)

60637

University of Chicago - American School Building, Chicago

All Listed Sponsors
collaborator

Northwestern University

OTHER

lead

University of Chicago

OTHER

NCT04720001 - Florbetaben PET Imaging in PPA | Biotech Hunter | Biotech Hunter